Yuping Sun

13PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 06, 2026
Efficacy and Safety of First-Line Treatment Options for Oncogene Wild-Type Lung Adenocarcinoma With Liver Metastases.

|Feb 11, 2026
Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study.

Minjiang Chen, Iurie Bulat, Marina Maglakelidze

|Sep 24, 2025
Targeting ILT4 to Improve Immunotherapy Efficacy in Solid Tumour: From Bench to Bedside.

Aiqin Gao, Shuyun Wang, Yuping Sun

|Jul 02, 2025
Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of extensive-stage small cell lung cancer.

Jian Zhang, Zijie Wu, Shuyun Wang

|Jun 07, 2025
Impact of irae characteristics on efficacy of consolidative immunotherapy following chemoradiotherapy in locally advanced NSCLC.

Xiufen Wang, Xuebing Fu, Qiaohong Liu

|Apr 22, 2025
Prognostic impact of the timing of immunotherapy in first-line immunochemotherapy for patients with advanced lung adenocarcinoma: A propensity score-matched analysis.

Yanxin Sun, Zhenzhen Deng, Haifeng Sun

Pageof 3

Frequent Collaborators

5 joint publications

Aiqin Gao

5 joint publications

Aiqin Gao

2 joint publications

Wenjing Shi

2 joint publications

Fang Zhang